Professor Joan Morris is the Director of the National Down Syndrome Cytogenetic Register. She has published work on the epidemiology of Down syndrome including quantifying the risk of a Down syndrome pregnancy to a woman who has had a previous affected pregnancy. She collaborates with congenital anomaly registers in Britain (BINOCAR) and Europe (EUROCAT) to investigate the epidemiology of other chromosomal and non-chromosomal anomalies. She collaborates with Professor Sir Nicholas Wald in evaluating the effectiveness of prenatal screening strategies for several different disorders, for example cystic fibrosis, fragile X syndrome, neural tube defects and Down syndrome. This work included mathematically modeling the population effect of cascade testing for a range of autosomal recessive disorders .She has been responsible for the statistical analysis involved in the work of Professor Wald and Professor Malcolm Law in a trio of papers in the British Medical Journal on the prevention of cardio-vascular disease by the use of the “Polypill”. This builds on the results from earlier meta-analyses of 354 trials on the effect of the value of low dose combination treatment with blood pressure lowering drugs, and meta-analyses on folate and serum homocysteine and cardiovascular disease.
Selected publications
- Morris, J K. Alberman, E. Scott, C. Jacobs, P. Is the prevalence of Klinefelter syndrome increasing? European Journal of Human Genetics (Available online 14/11/07 prior to full publication).
- Morris, J K. Wald, N J. The effect of correlations between screening markers on screening performance. Journal of Medical Screening. 2007;14:151-7.
- Morris, J K. Wald, N J. Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004. Journal of Medical Screening. 2007;14:55-9.
- Morris JK, Mutton DE, Alberman E. Recurrences of free trisomy 21: Analysis of data from the National Down Syndrome Cytogenetic Register. Prenatal Diagnosis 2005;25:1120-8.
- Law M, Morris JK, Jordan R, Wald N. Headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants. Circulation. 2005;112:2301-6.
- Morris JK, Wald NJ. Graphical presentation of distributions of risk in screening. J Med Screen. 2005;12:155-60.
- Morris JK, De Vignan C, Mutton DE, Alberman E. Risk of a Down syndrome live birth in women of 45 years of age and older. Prenatal Diagnosis 2005;25:275-8.
- Morris JK, Law MR, Wald NJ. Is cascade testing a sensible method of screening a population for autosomal recessive disorders? American Journal of Medical Genetics 2004;128:271-5.
- Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. British Medical Journal 2003;326:1427-1431
- Wald NJ, Morris JK. Teleoanalysis: combining data from different types of study. British Medical Journal 2003;327:616-618.

